Bill Commons

MA HD 4991

in committee

An Act relative to Medicare coverage of end-stage renal disease

Massachusetts · 2025-2026 Regular Session (194th General Court) · lower

Quick answers

Did MA HD 4991 pass?

Not yet. MA HD 4991 is in committee as of 2025-08-18 and has not come to a final vote. Latest recorded action (2025-08-18): Senate concurred

What is MA HD 4991 about?

By Representative Stanley of Waltham, a petition (subject to Joint Rule 12) of Thomas M. Stanley relative to Medicare coverage of end-stage renal disease. Health Care Financing.

Who sponsors MA HD 4991?

Thomas M. Stanley is the primary sponsor of MA HD 4991.

Description

By Representative Stanley of Waltham, a petition (subject to Joint Rule 12) of Thomas M. Stanley relative to Medicare coverage of end-stage renal disease. Health Care Financing.

Introduced
Latest action
2025-08-18 — Senate concurred
Bill type
proposed bill
Last updated

Sponsors

  • Thomas M. Stanleyprimary

Committees

Not provided by source.

Action timeline

  1. 2025-08-07

    Referred to the committee on House Rules

    referral-committee

  2. 2025-08-14

    Reported, referred to the committee on Joint Rules, reported, rules suspended and referred to the committee on Health Care Financing

    referral-committee

  3. 2025-08-18

    Senate concurred

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:56.590024Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MA&identifier=HD 4991. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.